August 1, 2025
Video: Faricimab Maintains Long-Term Stability in DME
Four-year data from the RHONE-X study, presented at ASRS, show sustained BCVA, CST improvements, and extended dosing potential in patients with diabetic macular edema.
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://pv-rp-staging.hbrsd.com/media/yrbnrfey/cover_july_aug25.jpg
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://pv-rp-staging.hbrsd.com/media/0amghqej/cover_julyaug25.jpg
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://pv-rp-staging.hbrsd.com/media/rnjiohrl/cover_june25_web.jpg
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://pv-rp-staging.hbrsd.com/media/5isnzmog/0725-op-cover-final-1.jpg
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://pv-rp-staging.hbrsd.com/media/upwdjelf/0725_cover_final.jpg
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://pv-rp-staging.hbrsd.com/media/aqbjxwjw/pp-cover.jpg
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://pv-rp-staging.hbrsd.com/media/npjdtl1w/cp_november_cover.jpg
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://pv-rp-staging.hbrsd.com/media/mvqdq2hc/nrp_cover_october_2024.jpg
August 1, 2025
Four-year data from the RHONE-X study, presented at ASRS, show sustained BCVA, CST improvements, and extended dosing potential in patients with diabetic macular edema.
By Veeral S. Sheth, MD, MBA, FACS
August 1, 2025
Luis Acabá-Berrocal, MD, shares 8-year outcomes of Gore-Tex–sutured IOLs in complex eyes.
By Luis A. Acabá-Berrocal, MD
August 1, 2025
In adult patients with a history of retinopathy of prematurity, rates of retinal tear or detachment after cataract surgery far exceed those in the general population.
By Jim Gallagher, senior managing editor
August 1, 2025
Interim data from TEASE‑3 presented at ASRS show stabilization of vision and retinal structure in patients with early-stage disease.
By Jim Gallagher, senior managing editor
August 1, 2025
David Almeida, MD, presented interim data from the SPECTRA trial of 4D-150 gene therapy in adults with diabetic macular edema
By DAVID R.P. ALMEIDA, MD, MBA, PHD
August 1, 2025
Avni Finn, MD, and Diana Do, MD, discuss promising results from the DAVIO2 trial of EYP-1901.
By Avni Finn, MD, MBA, Diana V. Do, MD
August 1, 2025
Chase Ludwig, MD, joins Diana V. Do, MD, to review real-world data suggesting that prompt laser in lattice eyes may reduce future retinal detachments.
By Chase Ludwig, MD, Diana V. Do, MD
July 31, 2025
What can AI learn from 1,000 retinal detachment cases? More than you’d think.
By Jim Gallagher, senior managing editor
July 31, 2025
A post hoc analysis of OAKS and DERBY data failed to support the foveal protection suggested by an earlier AREDS study.
By Paul Hahn, MD, PhD
July 31, 2025
Geoffrey G. Emerson, MD, PhD, talks about inclusion, innovation, and why early career engagement is key to the Society’s continuing development.
By Jim Gallagher, senior managing editor
July 31, 2025
Findings from the multisite trial of photobiomodulation suggest visual gains can persist after reinitiation of therapy.
By Jim Gallagher, senior managing editor
July 31, 2025
Maria Berrocal, MD, shares her approach to these challenging cases with Diana Do, MD. The first day of the 2025 ASRS meeting focused on surgical technique and innovation.
July 31, 2025
Gaurav Shah, MD, who planned the program for the annual meeting, explains why the first day was all about surgery.